Multiple Sclerosis Clinical Trials

Showing 461-480 of 5,093 trials

The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

NCT07351435

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.

Cardiogenic ShockMalignant ArrhythmiasIschemic or Valvular Heart Failure+8 more

University of Genova1,200 participantsStarted Feb 2026

TERMINATEDPhase 2

Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

NCT06006923

This is a trial of Regorafenib in combination with pembrolizumab for patients with MSI-H colorectal cancer consisting of lead-in phase examining preliminary efficacy and safety, followed by a randomized phase to further examine efficacy.

MSI-H Colorectal Cancer

Anwaar Saeed1 participantsStarted Jun 2024

Pittsburgh, Pennsylvania, United States

Active Not Recruiting

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

NCT03408379

Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.

Intracranial AneurysmsRuptured Aneurysm

Fondation Ophtalmologique Adolphe de Rothschild230 participantsStarted Dec 2017

Paris, France, France

The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

Related Searches

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis

The Effect of a Continuous 1-Hour Time Delay on Circadian Rhythms

Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor

The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis

Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

A Study of DM002 in Patients With Advanced Solid Tumors

Prostate Active Surveillance Study

Prevention of Retained Items iN Childbirth Environment and Surgical Sites

Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race

Efficacy of a Food Supplement in Relieving Premenstrual Syndrome Symptoms

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy

The Effect of Hemsball in the Older People

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)